Yang Zhi, Yao Feng-You, Long Yi-Tian, Meng Xue, Gao Liang-Chao, You Yi, Wen Miao, Pan Shu-Yue
Department of Radiology, Chengdu Fifth People's Hospital, Chengdu, China.
Department of Cardiology, Chengdu Fifth People's Hospital, Chengdu, China.
Ann Med. 2025 Dec;57(1):2533425. doi: 10.1080/07853890.2025.2533425. Epub 2025 Jul 23.
AIM/INTRODUCTION: There are two major distributions of late gadolinium enhancement (LGE) in the context of hypertrophic cardiomyopathy (HCM): intramural LGE and LGE at right ventricular insertion points (RVIPs). However, the clinical significance of intramural LGE has not been well established.
A total of 117 consecutive patients with HCM (61 male; median age, 58.8 years) confirmed by cardiovascular magnetic resonance (CMR) were enrolled, and classified into three groups: (1) no LGE ( = 48), (2) intramural LGE ( = 49), and (3) RVIP LGE ( = 20).
Intramural LGE was detected in 41% of patients with HCM. HCM patients with intramural LGE had greater left ventricular (LV) wall thickness (LVWT) and greater LV mass than those without LGE (all < 0.05). Furthermore, HCM patients with intramural LGE had a more depressed LV ejection fraction (LVEF) and more impaired global radial strain (GRS), global circumferential strain (GCS), and global longitudinal strain (GLS) than did those with RVIP LGE and those without LGE (all < 0.05). Multivariate logistic regression analysis revealed that young age and severely thickened LVWT were associated with intramural LGE in patients with HCM (all < 0.05). Furthermore, negative correlations were observed between intramural LGE and GRS, GCS, and GLS (all < 0.001).
Intramural LGE is associated with more severe HCM phenotypes, including a greater LVWT, LV mass and extent of LGE; a reduced LVEF; and impaired myocardial strain. These findings indicate that intramural LGE may be a noninvasive biomarker for risk stratification in patients with HCM.
目的/引言:在肥厚型心肌病(HCM)中,晚期钆增强(LGE)主要有两种分布情况:心肌内LGE和右心室插入点(RVIP)处的LGE。然而,心肌内LGE的临床意义尚未完全明确。
纳入117例经心血管磁共振(CMR)确诊的连续HCM患者(男性61例;中位年龄58.8岁),分为三组:(1)无LGE(n = 48),(2)心肌内LGE(n = 49),(3)RVIP处LGE(n = 20)。
41%的HCM患者检测到心肌内LGE。与无LGE的HCM患者相比,有心肌内LGE的HCM患者左心室(LV)壁厚度(LVWT)更大,左心室质量更高(均P < 0.05)。此外,与有RVIP处LGE的患者和无LGE的患者相比,有心肌内LGE的HCM患者左心室射血分数(LVEF)更低,整体径向应变(GRS)、整体圆周应变(GCS)和整体纵向应变(GLS)受损更严重(均P < 0.05)。多因素逻辑回归分析显示,年轻和LVWT严重增厚与HCM患者的心肌内LGE相关(均P < 0.05)。此外,心肌内LGE与GRS、GCS和GLS之间存在负相关(均P < 0.001)。
心肌内LGE与更严重的HCM表型相关,包括更大的LVWT、左心室质量和LGE范围;降低的LVEF;以及受损的心肌应变。这些发现表明,心肌内LGE可能是HCM患者风险分层的一种非侵入性生物标志物。